Indusatumab vedotin - CAS 1514889-12-3

Indusatumab vedotin (MLN-0264; AKT-264) is an antibody-drug conjugate (ADC) that combines a human anti-guanylate cyclase C (GCC) antibody with the microtubule-disruptor monomethyl auristatin E, demonstrating anti-proliferative effects on pancreatic cancer cell lines by arresting the cell cycle at the G2/M phase and inducing apoptosis [1].

Others, Antibody-Drug Conjugates (ADCs), Apoptosis, Guanylate cyclase

GPCR/G Protein, Apoptosis, Antibody-drug Conjugate/ADC Related, Others

1514889-12-3

-20°C

Ice Packs

Inhibitory Antibodies